Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
The Journal of Urology|April 1, 1989
Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trialsH J de Voogt, S Suciu, R Sylvester, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
The Children Leukemia Group: 30 years of research and achievementsJ Otten, N Philippe, S Suciu, et al.
Dermatology (Basel, Switzerland)|January 1, 1996
Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781)B M Henz, E Macher, E B Bröcker, et al.
Blut|January 1, 1988
Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML)H J Weh, R Kuse, R Hoffmann, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1989
Locoregional recurrences after 649 modified radical mastectomies: incidence and significanceG Andry, S Suciu, P Vico, et al.
Blood|September 1, 1983
Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adultsP A Stryckmans, J Otten, M J Delbeke, et al.
Leukemia|October 30, 2001
Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurineT Dervieux, Y Médard, P Verpillat, et al.
Haematology and Blood Transfusion|January 1, 1990
A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative GroupU Jehn, R Zittoun, S Suciu, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1988
Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC Leukemia Cooperative Group phase II studyR Willemze, U Jager, U Jehn, et al.
Leukemia|January 1, 1992
Mitoxantrone and high dose Ara-C for the treatment of ANLL in childhood: a pilot study of the EORTC CLCG (EORTC 58 872)C Béhar, Y Bertrand, H Rubie, et al.
Pageof 12